Next Article in Journal
Pediatric Traumatic Brain Injury in the United States: Rural-Urban Disparities and Considerations
Next Article in Special Issue
The Role of Sartans in the Treatment of Stroke and Subarachnoid Hemorrhage: A Narrative Review of Preclinical and Clinical Studies
Previous Article in Journal
Cannabis and Cognition: Connecting the Dots towards the Understanding of the Relationship
Previous Article in Special Issue
Saccular Aneurysm Models Featuring Growth and Rupture: A Systematic Review
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Preclinical Intracranial Aneurysm Models: A Systematic Review

1
Department of Neurosurgery, 5001 Kantonsspital Aarau, Switzerland
2
Cerebrovascular Research Group, Department for BioMedical Research, University of Bern, 3008 Bern, Switzerland
*
Author to whom correspondence should be addressed.
Brain Sci. 2020, 10(3), 134; https://doi.org/10.3390/brainsci10030134
Submission received: 31 January 2020 / Revised: 21 February 2020 / Accepted: 23 February 2020 / Published: 27 February 2020

Abstract

:
Intracranial aneurysms (IA) are characterized by weakened cerebral vessel walls that may lead to rupture and subarachnoid hemorrhage. The mechanisms behind their formation and progression are yet unclear and warrant preclinical studies. This systematic review aims to provide a comprehensive, systematic overview of available animal models for the study of IA pathobiology. We conducted a systematic literature search using the PubMed database to identify preclinical studies employing IA animal models. Suitable articles were selected based on predefined eligibility criteria following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Included studies were reviewed and categorized according to the experimental animal and aneurysm model. Of 4266 returned results, 3930 articles were excluded based on the title and/or abstract and further articles after screening the full text, leaving 123 studies for detailed analysis. A total of 20 different models were found in rats (nine), mice (five), rabbits (four), and dogs (two). Rat models constituted the most frequently employed intracranial experimental aneurysm model (79 studies), followed by mice (31 studies), rabbits (12 studies), and two studies in dogs. The most common techniques to induce cerebral aneurysms were surgical ligation of the common carotid artery with subsequent induction of hypertension by ligation of the renal arteries, followed by elastase-induced creation of IAs in combination with corticosterone- or angiotensin-induced hypertension. This review provides a comprehensive summary of the multitude of available IA models to study various aspects of aneurysm formation, growth, and rupture. It will serve as a useful reference for researchers by facilitating the selection of the most appropriate model and technique to answer their scientific question.

1. Introduction

Intracranial aneurysm (IA) refers to an outward bulging of the arterial wall and is a serious cerebrovascular disease with a high morbidity and mortality [1]. It is characterized by a chronic inflammation and weakening of the arterial walls [2]. The prognosis of IA is poor, due to a rupture of the lesions and the ensuing subarachnoid hemorrhage that is responsible for the high number of IA-induced fatalities. Even though the prevalence of IA is high (2–8% [3]), there is currently no proven therapy that achieves stabilization and prevention of rupture. Most IA patients are treated conservatively, and only those with a presumably high risk of IA rupture (depending on the IA size, smoking status and location [4]) undergo occlusion [5]. The successful development and implementation of therapeutic strategies to avoid IA formation, and particularly subarachnoid hemorrhage, is hence of clinical importance. A prerequisite for any effective therapy is a better understanding of IA pathobiology. Moreover, both the efficacy and potential side effects of a novel drug need to be carefully assessed before it may be administered to IA patients, requiring a thorough preclinical investigation that precedes the translation in the clinical practice. Since the natural formation of IA is rare in animals, techniques to artificially induce IA in experimental animals have been developed. Researchers interested in the study of IA pathobiology are now facing a broad variety of animal models to choose from [6]. These involve models in different species and numerous variations of the originally developed methods, which differ in their comparability to human IAs, the complexity of the methodology, and the questions that can be answered. Furthermore, the technique to induce hypertension constitutes a common variation of the initial, well-established models. The large volume of available models may complicate the selection of the appropriate model for the respective research question. We therefore set out to compile systematic literature review on available IA animal models as a comprehensive reference for researchers planning to employ such a model in their investigations. We discuss advantages and disadvantages of each model and address considerations regarding the species and method of choice.

2. Materials and Methods

A systematic literature search in the Medline/PubMed database was conducted to identify preclinical studies using IA animal models. The search was performed on November 31, 2017 with the keywords “mice”, “rat”, “rabbit”, “dog”, and “swine” in combination with “aneurysm” using the Boolean operator [AND]. Studies on primates were excluded due to their limited ethical justifiability. The search was restricted to “animals”. Two investigators (SM and FS) independently screened titles and abstracts and selected suitable studies based on predefined eligibility criteria following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [7]. The final articles to be included were selected based on the full text of eligible studies. Discrepancies in the study selection were discussed with all authors and a consensus was reached. Included studies were reviewed and categorized according to the experimental animal used and the aneurysm model employed.
The eligibility criteria were as follows: (1) in vivo IA model in the experimental species rat, mouse, rabbit, dog, and swine; (2) English language; (3) original research article (reviews, letters, and editorials were excluded).
The following data were extracted from eligible full text articles: (1) authors and year of publication; (2) study question and main conclusion; (3) animal species; (4) method to create IA; (5) IA location; and (6) time until sacrifice/study duration.
The same method to generate IA in different species was considered a separate model. Modifications of an existing model such as extension of the technique itself or of significant accessory techniques (e.g., induction of hypertension by renal artery (RA) ligation) were also categorized as individual models.

3. Results

The literature searches initially returned 4264 articles, of which 3930 were excluded after title and/or abstract screening because they did not meet the eligibility criteria. A further 211 articles were excluded after screening the full text due to one or more of the following reasons: duplicate article, article was withdrawn, the type of article differed from an original research study such as a review, letter or comment, or the article was written in a language other than English. This strategy left 123 studies for a detailed analysis (Figure 1).
A total of 20 different models were identified based on the technique to create IA (common carotid artery (CCA) ligation (unilateral or bilateral), (renal artery [RA] ligation [unilateral or bilateral], elastase injection [with or without CCA ligation] and experimental species [rat, mouse, rabbit, dog])) (Table 1). Only those modifications that affected the ligation surgery (i.e., RA ligation or not) were considered as separate models. Smaller variations to the induction of hypertension (i.e., different NaCl concentrations, β-aminopropionitrile monofumarate (BAPN) or estrogen depletion) were not considered as novel models. Of the identified distinct models, 9 different models were used in rats, 5 in mice, 4 in rabbits, and 2 in dogs (see Table 1 for detailed listing of studies according to the IA model). The identified IA animal models were assigned to one of the following main categories: (1) CCA ligation with concomitant RA ligation, (2) CCA ligation only, (3) elastase injection, (4) elastase injection and CCA ligation, or (5) another model.
The most common technique to induce cerebral aneurysms was surgical ligation of the CCA and/or the RA with concomitant induction of hypertension (64 studies), followed by CCA ligation without RA manipulation (24 studies) and elastase-induced creation of IAs in combination with corticosterone- or angiotensin II-induced hypertension (24 studies, see Table 2 for an overview of IA model by experimental animal). Thirteen studies employed alternative methods to create IA. Of the models using CCA ligation, unilateral ligation of the left CCA was performed in most models, but ligation of the right CCA or bilateral ligation was also common. CCA ligation was most common in rats and rabbits, whereas the elastase method was used in most mouse models. The category “other models” included IA creation by deoxycorticosterone administration [121], eplerenone administration [122], induction of copper deficiency [123], CaCl2 treatment [124], coating of the internal carotid artery [125], with one study for each of these models.
Most of the assessed studies used rats for their animal model (79 studies), followed by mice (31 studies), and rabbits (12 studies). Only two studies were performed in dogs. Almost half of the mouse models were employed in transgenic animals [22,41,43,53,92,95,96,99,102,105,106,109,112,114,127].
The most frequent variation of the original models was modification of the technique to induce hypertension rather than of the IA creation technique itself. Hypertension was typically achieved by using one or a combination of RA ligation, high salt diet, or deoxycorticosterone administration (Table 3). A further variation of the original CCA model was omission of BAPN administration to inhibit cross-linking of collagen and elastin, which was contraindicated depending on certain research questions [56].
The study duration before sacrifice and assessment of the animal varied between a few weeks [38,105] and a year [16,71], but typically lasted 1 to 3 months.

4. Discussion

By conducting a comprehensive systematic review of the literature, we achieved categorization of the IA animal models available to date and developed an overview that should facilitate the choice of the experimental animal and most appropriate technique for researchers interested in IA pathobiology. Surgical ligation of the CCA and elastase-induced weakening of the arterial vessel wall was identified as the predominant techniques to create IA in experimental animals. A brief discussion of the advantages and disadvantages of each of these categories follows.

General Considerations

Ethics: Animal ethics regulations have become increasingly strict in recent years in terms of the species of animal and required numbers to be used in experimental studies. Studies on animals that raise particular ethical concerns, such as those conducted in dogs, primates and swine, are likely to face more obstacles throughout the animal ethics approval process, which may delay the conduction of the study or entirely prevent its completion. Small animals that are more commonly used in research such as rats and mice appear often more feasible than those in large animals, yet the study needs to be carefully designed to ensure statistically feasible justification of the required animal numbers, particularly in cases where it is unknown if and for how long the animals will survive the experiment, as is the case for all intracranial animal models.
Costs: Similar to the ethical concerns, the maintenance and housing of large animals can infer tremendous costs on the researcher. In addition, the potential costs need to consider the duration of the experiments, as some of the aneurysm models last for more than three months, during which time the animals need to be housed and likely monitored daily, which results in additional costs for animal care personnel and veterinarians.
Reliability: Most intracranial aneurysm models are conducted in rats by unilateral CCA ligation and concomitant RA ligation (Table 2). This can be attributed to the reliability of such a model in producing aneurysms in the majority of experimental animals in a comparatively very short period of time of less than three months (Table 3). These models are so reliable because they are based on a long history of refinement and modifications, Table S1 tweaking the technique to a point where aneurysm development is guaranteed. An even faster generation of aneurysms is observed in the elastase model in mice, yet it appears that this model does not work well in rats, therefore one needs to balance the time of formation with the most suitable species for the experiment. The best model clearly depends on the research question to be answered. If aneurysm growth is the main factor to be investigated, surgical ligation models are to be favored over others, as the procedure allows for variation in the size of the aneurysm and may generate very large aneurysms in the animals. In turn, if aneurysm rupture is the center of the investigation, the surgical model needs to be combined with a treatment to induce hypertension such as administering NaCl in the drinking water or implanting a salt pellet with dosed release. Alternatively, the elastase model is frequently used in mechanistic and pharmacological aneurysm rupture studies as it generates ruptures through subarachnoid hemorrhages within a relatively short period of time (one month).
Ligation of the CCA, with or without concomitant RA ligation: This original model first described in the 1970s by Hashimoto et al. [11] and Nagata et al. [78] involves unilateral ligation of the CCA, for which most frequently the left CCA is manipulated. The ligation is accompanied by additional induction of hypertension using either ligation of one or both RAs, feeding of a high salt diet, administration of deoxycorticosterone, or a combination of these parameters (Table 4). In order to increase the animal’s susceptibility to IA formation and shortening of the IA induction time, CCA ligation may be combined with administration of β-aminopropionitrile, a lathyrogen that inhibits the cross-linking of collagen and elastin, or with estrogen depletion achieved by oophorectomy to compromise endothelial cell function and NO (nitrogen oxide) release. Most rat models employ unilateral CCA ligation combined with bilateral RA ligation and a high salt diet, while in rabbits, both CCAs are often ligated without any further means of inducing hypertension. In mice, unilateral CCA ligation was complemented by contralateral ligation of one RA.
The major advantage of this model is that is has been well established and refined for decades and has been shown to reliably induce IA in rats, mice and rabbits. It has been employed to answer a broad variety of research questions, ranging from the contribution of isolated factors to aneurysm formation to the success of therapeutic agents in the prevention and treatment of IAs.
Elastase treatment: As an alternative to the classical vessel ligation model, several more recent studies employ the injection of elastase into the cerebrospinal fluid or a common artery to disrupt the elastic lamina and thereby weaken the vessel walls. Concomitant induction of hypertension is achieved by continuous administration of angiotensin II with the aid of an implanted osmotic mini-pump, or by a combined administration of a high salt diet and deoxycorticosterone. This model is employed in mice and rabbits but rarely in rats. It accomplishes creation of large aneurysms within a relatively short study period. In a few models, both the injection of elastase and artery ligation were performed.
Elastase treatment and ligation of the CCA: IA generation by elastase injection may be supported by concomitant ligation of the CCA. We identified only four studies that employed this model, and mice were the only experimental animal used. Hence, this model has apparently not been tested in other experimental animals. Of note, this model involved the shortest study period, with IA creation achieved several days following the induction and a mean generation time of less than half a month (Figure 2, Table 3).
Once the type of IA model has been identified, the choice of experimental animal species must be considered, considering that the situation in the animal should be comparable to human IA pathophysiology. Most IA models are performed in small animals such as rats and mice. A limitation of all models is that IA do not easily develop spontaneously in animals and hence always constitute an artificially induced entity.
Certain models apparently work better in one species than the other [25]. The total study duration needs to be estimated; e.g., how long does it take to induce an aneurysm in an animal, and is this duration feasible for the study setting? We performed a meta-analysis of all selected studies with regards to the time it took to develop IAs following the induction (Figure 2, Table 3). Elastase injection alone (0.65 ± 0.43 months), or in combination with CCA ligation (0.43 ± 0.38 months), required a shorter time for IA generation than CCA alone (2.53 ± 3.33 months) or in combination with RA ligation (2.38 ± 2.48 months; Figure 2). The shortest study period was observed in a mouse model with elastase injection (0.1 month), while a model with CCA ligation in mice (13 months) took the longest (Table 3).
In addition, the number of animals that can be used is determined by the breeding time, housing space and animal care cost, and is to be carefully considered to obtain an animal number that can reach statistical significance (Collaborative Approach to Meta-Analysis and Review of Animal Data from Experimental Studies/CAMARADES [128]). Furthermore, different strains of the same species may differ in their susceptibility to IA formation [36]. Practical aspects also play a role in the species choice, such as the space that is required for the surgery (e.g., can it be done in a designated laboratory space or is an operating theater required) and the level of difficulty of the surgery itself (e.g., is an anesthesiologist required, how technically challenging is the surgery). The estimation of whether the respective research question can be appropriately answered with the experimental animal species is of utmost importance. For example, if the contribution of an isolated factor is to be investigated, a strain with a genetic knockdown of the gene of choice may be useful, which then renders a genetic mouse model the most suitable choice. Animal ethics need to be considered as well, as canine studies are not only expensive but also ethically challenging. Concerns over the ethical treatment of animals led to the development of the “3R principle” that aims to replace, reduce, or refine experiments using experimental animals; owing to this principle, primates are rarely used these days as research models. For this reason, we did not extend the scope of the present review to this species as they are only employed in exceptional cases. Advantages and disadvantages of each model are discussed as follows.
Rats: The major advantage of using rats as an experimental model is the availability of a well-established model that works well and has been described in detail with slight variations for decades. CCA ligation in combination with RA ligation appears to be the gold standard for IA creation, and the investigator can make a well informed choice of the experimental specifications due to the plethora of available literature. Furthermore, rats are commonly used experimental animals, are easily available, instill only moderate costs for housing and feed, and breed fast, making it possible to conduct studies with many animals to reach statistical significance. Moreover, anesthetic techniques are well established in this species and can be easily maintained in a typical research laboratory without the need for a designated operating theater or a veterinary anesthesiologist. The surgery is manageable (not as small as in the mouse but still comparable to humans) and may be relatively easily learned by a new scientist entering the field. The disadvantage of using rats is that the elastase model apparently does not work as well in rats as in mice, and neither does bilateral CCA ligation should it be required. In addition, although genetic knockout models in rats are available, they generate considerably higher costs compared to such models in mice.
Mice: Mice share the same practical advantages as rats, in that their housing and feed is comparatively cheap, they breed fast, and are well maintained during surgery on basic anesthetic techniques. The major advantage of using mice as an experimental model is the possibility to investigate an isolated factor that may contribute to IA formation or protect from it in transgenic animals, be it knockout mouse models or animals overexpressing certain genes. Particularly, the elastase model is well established in mice, and the CCA ligation model has also been successfully employed in this species. A disadvantage of using mice may be the somewhat delicate surgery on very small vessels, which could require some practice to achieve an optimum outcome.
Rabbits: Bilateral CCA ligation is particularly well established in rabbits and appears to work better in this species than in rats. None of the studies included in this review employed RA ligation in rabbits, and only one study described the elastase model. In terms of practicability, rabbits incur a somewhat larger cost for housing than rats and mice as they require more space. It may also not be possible to conduct surgery on these animals in any regular laboratory space, but rather an operating theater might be required.
Dogs: We identified only two studies using distinct IA models in dogs as experimental animals, both of which were dated (1977 and 1984). It has to be noted that angiography is an investigative technique available for dogs that does not require sacrifice of the animal. Nevertheless, it appears that both the much more extensive cost in combination with ethical considerations does not render this species a model that can be routinely employed. The same holds true for swine and primates as experimental animals to create IAs. Few studies exist that use large species to produce IAs. The few published studies are considered historical series rather than models that are still in use today. Considering ethical concerns, it is unlikely that these species/models will gain importance in the future.

5. Conclusions

We provide a categorization of available IA animal models and thereby present a tool to guide researchers entering the field of aneurysm pathobiology. The best choice of a specific IA model strongly depends on the individual research question and numerous other factors such as the primary endpoint, available resources (e.g., expenses for animal housing and breeding, space for surgical procedures, need for veterinary anesthesiologist), and time frame for IA initiation, growth, and rupture (weeks to months).

Supplementary Materials

The following are available online at https://www.mdpi.com/2076-3425/10/3/134/s1, Table S1: Incidence of Aneurysm development.

Author Contributions

F.S. and S.M.: design of the systematic review, collection and analysis of data, drafting the manuscript; F.S., S.M., B.E.G. and J.F.: critical revision of the first draft; all of the authors: critical revision of the final manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by a research grant from the Kantonsspital Aarau, Aarau, Switzerland (FR 1400.000.054).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Etminan, N.; Rinkel, G.J. Unruptured intracranial aneurysms: Development, rupture and preventive management. Nat. Rev. Neurol. 2016, 12, 699–713. [Google Scholar] [CrossRef] [PubMed]
  2. Fukuda, M.; Aoki, T. Molecular basis for intracranial aneurysm formation. Acta Neurochir. Suppl. 2015, 120, 13–15. [Google Scholar] [CrossRef] [PubMed]
  3. Vlak, M.H.; Algra, A.; Brandenburg, R.; Rinkel, G.J. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: A systematic review and meta-analysis. Lancet Neurol. 2011, 10, 626–636. [Google Scholar] [CrossRef]
  4. Brinjikji, W.; Pereira, V.M.; Khumtong, R.; Kostensky, A.; Tymianski, M.; Krings, T.; Radovanovich, I. PHASES and ELAPSS scores are associated with aneurysm growth: A study of 431 unruptured intracranial aneurysms. World Neurosurg. 2018, 114, e425–e432. [Google Scholar] [CrossRef] [PubMed]
  5. Diaz, O.; Rangel-Castilla, L. Endovascular treatment of intracranial aneurysms. Handb. Clin. Neurol. 2016, 136, 1303–1309. [Google Scholar] [CrossRef]
  6. Bouzeghrane, F.; Naggara, O.; Kallmes, D.F.; Berenstein, A.; Raymond, J.; International Consortium of Neuro Endovascular Centres. In vivo experimental intracranial aneurysm models: A systematic review. AJNR Am. J. Neuroradiol. 2010, 31, 418–423. [Google Scholar] [CrossRef] [Green Version]
  7. Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G.; Group, P. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Int. J. Surg. 2010, 8, 336–341. [Google Scholar] [CrossRef] [Green Version]
  8. Alvarez, F.; Roda, J.M. Experimental model for induction of cerebral aneurysms in rats. J. Neurosurg. 1986, 65, 398–400. [Google Scholar] [CrossRef]
  9. Cai, J.; He, C.; Yuan, F.; Chen, L.; Ling, F. A novel haemodynamic cerebral aneurysm model of rats with normal blood pressure. J. Clin. Neurosci. 2012, 19, 135–138. [Google Scholar] [CrossRef]
  10. Coutard, M.; Huang, W.; Osborne-Pellegrin, M. Heritability of intracerebral hemorrhagic lesions and cerebral aneurysms in the rat. Stroke 2000, 31, 2678–2684. [Google Scholar] [CrossRef] [Green Version]
  11. Hashimoto, N.; Handa, H.; Hazama, F. Experimentally induced cerebral aneurysms in rats. Surg. Neurol. 1978, 10, 3–8. [Google Scholar] [PubMed]
  12. Hashimoto, N.; Handa, H.; Hazama, F. Experimentally induced cerebral aneurysms in rats: Part II. Surg. Neurol. 1979, 11, 243–246. [Google Scholar] [PubMed]
  13. Hashimoto, N.; Handa, H.; Hazama, F. Experimentally induced cerebral aneurysms in rats: Part III. Pathology. Surg. Neurol. 1979, 11, 299–304. [Google Scholar] [PubMed]
  14. Hashimoto, N.; Handa, H.; Nagata, I.; Hazama, F. Experimentally induced cerebral aneurysms in rats: Part V. Relation of hemodynamics in the circle of Willis to formation of aneurysms. Surg. Neurol. 1980, 13, 41–45. [Google Scholar]
  15. Ishibashi, R.; Aoki, T.; Nishimura, M.; Miyamoto, S. Imidapril inhibits cerebral aneurysm formation in an angiotensin-converting enzyme-independent and matrix metalloproteinase-9-dependent manner. Neurosurgery 2012, 70, 722–730. [Google Scholar] [CrossRef]
  16. Kaufmann, T.J.; Marx, W.F.; Kallmes, D.F. A failure of matrix metalloproteinase inhibition in the prevention of rat intracranial aneurysm formation. Neuroradiology 2006, 48, 190–195. [Google Scholar] [CrossRef]
  17. Matsushita, N.; Kitazato, K.T.; Tada, Y.; Sumiyoshi, M.; Shimada, K.; Yagi, K.; Kanematsu, Y.; Satomi, J.; Nagahiro, S. Increase in body Na+/water ratio is associated with cerebral aneurysm formation in oophorectomized rats. Hypertension 2012, 60, 1309–1315. [Google Scholar] [CrossRef] [Green Version]
  18. Suzuki, S.; Robertson, J.T.; White, R.P.; Stadlan, E.M.; Popoff, N. Experimental intracranial aneurysms in rats. A gross and microscopic study. J. Neurosurg. 1980, 52, 494–500. [Google Scholar] [CrossRef]
  19. Roda, J.M.; Alvarez, F.; Garcia-Villalon, A.L.; Ruiz, M.R.; Gutierrez, M.; Garcia Blazquez, M. An increment in unilateral carotid blood flow produces cerebral aneurysms in rats. Acta Neurochir. Suppl. (Wien) 1988, 43, 189–192. [Google Scholar]
  20. Xu, Y.; Tian, Y.; Wei, H.J.; Chen, J.; Dong, J.F.; Zacharek, A.; Zhang, J.N. Erythropoietin increases circulating endothelial progenitor cells and reduces the formation and progression of cerebral aneurysm in rats. Neuroscience 2011, 181, 292–299. [Google Scholar] [CrossRef]
  21. Xu, Y.; Tian, Y.; Wei, H.J.; Dong, J.F.; Zhang, J.N. Methionine diet-induced hyperhomocysteinemia accelerates cerebral aneurysm formation in rats. Neurosci. Lett. 2011, 494, 139–144. [Google Scholar] [CrossRef] [PubMed]
  22. Abruzzo, T.; Kendler, A.; Apkarian, R.; Workman, M.; Khoury, J.C.; Cloft, H.J. Cerebral aneurysm formation in nitric oxide synthase-3 knockout mice. Curr. Neurovasc. Res. 2007, 4, 161–169. [Google Scholar] [CrossRef] [PubMed]
  23. Dai, D.; Ding, Y.H.; Kadirvel, R.; Rad, A.E.; Lewis, D.A.; Kallmes, D.F. Lack of aneurysm formation after carotid artery ligation in rabbits: A polymer MICROFIL(R) study. Neuroradiology 2013, 55, 65–70. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Gao, L.; Hoi, Y.; Swartz, D.D.; Kolega, J.; Siddiqui, A.; Meng, H. Nascent aneurysm formation at the basilar terminus induced by hemodynamics. Stroke 2008, 39, 2085–2090. [Google Scholar] [CrossRef]
  25. Tutino, V.M.; Liaw, N.; Spernyak, J.A.; Ionita, C.N.; Siddiqui, A.H.; Kolega, J.; Meng, H. Assessment of vascular geometry for bilateral carotid artery ligation to induce early basilar terminus aneurysmal remodeling in rats. Curr. Neurovasc. Res. 2016, 13, 82–92. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Dolan, J.M.; Meng, H.; Sim, F.J.; Kolega, J. Differential gene expression by endothelial cells under positive and negative streamwise gradients of high wall shear stress. Am. J. Physiol. Cell Physiol. 2013, 305, C854–C866. [Google Scholar] [CrossRef] [Green Version]
  27. Kolega, J.; Gao, L.; Mandelbaum, M.; Mocco, J.; Siddiqui, A.H.; Natarajan, S.K.; Meng, H. Cellular and molecular responses of the basilar terminus to hemodynamics during intracranial aneurysm initiation in a rabbit model. J. Vasc. Res. 2011, 48, 429–442. [Google Scholar] [CrossRef] [Green Version]
  28. Li, M.H.; Li, P.G.; Huang, Q.L.; Ling, J. Endothelial injury preceding intracranial aneurysm formation in rabbits. West Indian Med. J. 2014, 63, 167–171. [Google Scholar] [CrossRef] [Green Version]
  29. Liaw, N.; Fox, J.M.; Siddiqui, A.H.; Meng, H.; Kolega, J. Endothelial nitric oxide synthase and superoxide mediate hemodynamic initiation of intracranial aneurysms. PLoS ONE 2014, 9, e101721. [Google Scholar] [CrossRef]
  30. Mandelbaum, M.; Kolega, J.; Dolan, J.M.; Siddiqui, A.H.; Meng, H. A critical role for proinflammatory behavior of smooth muscle cells in hemodynamic initiation of intracranial aneurysm. PLoS ONE 2013, 8, e74357. [Google Scholar] [CrossRef]
  31. Metaxa, E.; Tremmel, M.; Natarajan, S.K.; Xiang, J.; Paluch, R.A.; Mandelbaum, M.; Siddiqui, A.H.; Kolega, J.; Mocco, J.; Meng, H. Characterization of critical hemodynamics contributing to aneurysmal remodeling at the basilar terminus in a rabbit model. Stroke 2010, 41, 1774–1782. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Tutino, V.M.; Mandelbaum, M.; Choi, H.; Pope, L.C.; Siddiqui, A.; Kolega, J.; Meng, H. Aneurysmal remodeling in the circle of Willis after carotid occlusion in an experimental model. J. Cereb. Blood Flow Metab. 2014, 34, 415–424. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Tutino, V.M.; Mandelbaum, M.; Takahashi, A.; Pope, L.C.; Siddiqui, A.; Kolega, J.; Meng, H. Hypertension and estrogen deficiency augment aneurysmal remodeling in the rabbit circle of willis in response to carotid ligation. Anat. Rec. (Hoboken) 2015, 298, 1903–1910. [Google Scholar] [CrossRef] [Green Version]
  34. Aoki, T.; Kataoka, H.; Moriwaki, T.; Nozaki, K.; Hashimoto, N. Role of TIMP-1 and TIMP-2 in the progression of cerebral aneurysms. Stroke 2007, 38, 2337–2345. [Google Scholar] [CrossRef] [Green Version]
  35. Aoki, T.; Fukuda, M.; Nishimura, M.; Nozaki, K.; Narumiya, S. Critical role of TNF-alpha-TNFR1 signaling in intracranial aneurysm formation. Acta Neuropathol. Commun. 2014, 2, 34. [Google Scholar] [CrossRef] [Green Version]
  36. Coutard, M.; Osborne-Pellegrin, M. Genetic susceptibility to experimental cerebral aneurysm formation in the rat. Stroke 1997, 28, 1035–1041. [Google Scholar] [CrossRef]
  37. Fukuda, M.; Aoki, T.; Manabe, T.; Maekawa, A.; Shirakawa, T.; Kataoka, H.; Takagi, Y.; Miyamoto, S.; Narumiya, S. Exacerbation of intracranial aneurysm and aortic dissection in hypertensive rat treated with the prostaglandin F-receptor antagonist AS604872. J. Pharmacol. Sci. 2014, 126, 230–242. [Google Scholar] [CrossRef] [Green Version]
  38. Ikedo, T.; Minami, M.; Kataoka, H.; Hayashi, K.; Nagata, M.; Fujikawa, R.; Higuchi, S.; Yasui, M.; Aoki, T.; Fukuda, M.; et al. Dipeptidyl peptidase-4 inhibitor anagliptin prevents intracranial aneurysm growth by suppressing macrophage infiltration and activation. J. Am. Heart Assoc. 2017, 6. [Google Scholar] [CrossRef]
  39. Miyata, H.; Koseki, H.; Takizawa, K.; Kasuya, H.; Nozaki, K.; Narumiya, S.; Aoki, T. T cell function is dispensable for intracranial aneurysm formation and progression. PLoS ONE 2017, 12, e0175421. [Google Scholar] [CrossRef] [Green Version]
  40. Yamamoto, R.; Aoki, T.; Koseki, H.; Fukuda, M.; Hirose, J.; Tsuji, K.; Takizawa, K.; Nakamura, S.; Miyata, H.; Hamakawa, N.; et al. A sphingosine-1-phosphate receptor type 1 agonist, ASP4058, suppresses intracranial aneurysm through promoting endothelial integrity and blocking macrophage transmigration. Br. J. Pharmacol. 2017, 174, 2085–2101. [Google Scholar] [CrossRef] [Green Version]
  41. Moriwaki, T.; Takagi, Y.; Sadamasa, N.; Aoki, T.; Nozaki, K.; Hashimoto, N. Impaired progression of cerebral aneurysms in interleukin-1beta-deficient mice. Stroke 2006, 37, 900–905. [Google Scholar] [CrossRef] [PubMed]
  42. Aoki, T.; Kataoka, H.; Morimoto, M.; Nozaki, K.; Hashimoto, N. Macrophage-derived matrix metalloproteinase-2 and -9 promote the progression of cerebral aneurysms in rats. Stroke 2007, 38, 162–169. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  43. Aoki, T.; Kataoka, H.; Shimamura, M.; Nakagami, H.; Wakayama, K.; Moriwaki, T.; Ishibashi, R.; Nozaki, K.; Morishita, R.; Hashimoto, N. NF-kappaB is a key mediator of cerebral aneurysm formation. Circulation 2007, 116, 2830–2840. [Google Scholar] [CrossRef] [Green Version]
  44. Aoki, T.; Kataoka, H.; Ishibashi, R.; Nozaki, K.; Hashimoto, N. Simvastatin suppresses the progression of experimentally induced cerebral aneurysms in rats. Stroke 2008, 39, 1276–1285. [Google Scholar] [CrossRef]
  45. Aoki, T.; Kataoka, H.; Ishibashi, R.; Nozaki, K.; Hashimoto, N. Gene expression profile of the intima and media of experimentally induced cerebral aneurysms in rats by laser-microdissection and microarray techniques. Int. J. Mol. Med. 2008, 22, 595–603. [Google Scholar]
  46. Aoki, T.; Kataoka, H.; Ishibashi, R.; Nozaki, K.; Hashimoto, N. Cathepsin B, K, and S are expressed in cerebral aneurysms and promote the progression of cerebral aneurysms. Stroke 2008, 39, 2603–2610. [Google Scholar] [CrossRef]
  47. Aoki, T.; Moriwaki, T.; Takagi, Y.; Kataoka, H.; Yang, J.; Nozaki, K.; Hashimoto, N. The efficacy of apolipoprotein E deficiency in cerebral aneurysm formation. Int. J. Mol. Med. 2008, 21, 453–459. [Google Scholar] [CrossRef] [Green Version]
  48. Aoki, T.; Kataoka, H.; Ishibashi, R.; Nakagami, H.; Nozaki, K.; Morishita, R.; Hashimoto, N. Pitavastatin suppresses formation and progression of cerebral aneurysms through inhibition of the nuclear factor kappaB pathway. Neurosurgery 2009, 64, 357–365. [Google Scholar] [CrossRef]
  49. Aoki, T.; Kataoka, H.; Nishimura, M.; Ishibashi, R.; Morishita, R.; Miyamoto, S. Ets-1 promotes the progression of cerebral aneurysm by inducing the expression of MCP-1 in vascular smooth muscle cells. Gene Ther. 2010, 17, 1117–1123. [Google Scholar] [CrossRef]
  50. Aoki, T.; Nishimura, M.; Ishibashi, R.; Kataoka, H.; Takagi, Y.; Hashimoto, N. Toll-like receptor 4 expression during cerebral aneurysm formation. Laboratory investigation. J. Neurosurg. 2010, 113, 851–858. [Google Scholar] [CrossRef]
  51. Aoki, T.; Nishimura, M.; Kataoka, H.; Ishibashi, R.; Nozaki, K.; Miyamoto, S. Complementary inhibition of cerebral aneurysm formation by eNOS and nNOS. Lab. Investig. 2011, 91, 619–626. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Aoki, T.; Kataoka, H.; Nishimura, M.; Ishibashi, R.; Morishita, R.; Miyamoto, S. Regression of intracranial aneurysms by simultaneous inhibition of nuclear factor-kappaB and Ets with chimeric decoy oligodeoxynucleotide treatment. Neurosurgery 2012, 70, 1534–1543. [Google Scholar] [CrossRef] [PubMed]
  53. Aoki, T.; Frosen, J.; Fukuda, M.; Bando, K.; Shioi, G.; Tsuji, K.; Ollikainen, E.; Nozaki, K.; Laakkonen, J.; Narumiya, S. Prostaglandin E2-EP2-NF-kappaB signaling in macrophages as a potential therapeutic target for intracranial aneurysms. Sci. Signal. 2017, 10. [Google Scholar] [CrossRef] [Green Version]
  54. Aoki, T.; Saito, M.; Koseki, H.; Tsuji, K.; Tsuji, A.; Murata, K.; Kasuya, H.; Morita, A.; Narumiya, S.; Nozaki, K.; et al. Macrophage imaging of cerebral aneurysms with ferumoxytol: An exploratory study in an animal model and in patients. J. Stroke Cerebrovasc. Dis. 2017, 26, 2055–2064. [Google Scholar] [CrossRef] [PubMed]
  55. Eldawoody, H.; Shimizu, H.; Kimura, N.; Saito, A.; Nakayama, T.; Takahashi, A.; Tominaga, T. Simplified experimental cerebral aneurysm model in rats: Comprehensive evaluation of induced aneurysms and arterial changes in the circle of Willis. Brain Res. 2009, 1300, 159–168. [Google Scholar] [CrossRef]
  56. Futami, K.; Yamashita, J.; Tachibana, O.; Higashi, S.; Ikeda, K.; Yamashima, T. Immunohistochemical alterations of fibronectin during the formation and proliferative repair of experimental cerebral aneurysms in rats. Stroke 1995, 26, 1659–1664. [Google Scholar] [CrossRef] [PubMed]
  57. Futami, K.; Yamashita, J.; Tachibana, O.; Kida, S.; Higashi, S.; Ikeda, K.; Yamashima, T. Basic fibroblast growth factor may repair experimental cerebral aneurysms in rats. Stroke 1995, 26, 1649–1654. [Google Scholar] [CrossRef]
  58. Futami, K.; Yamashita, J.; Higashi, S. Do cerebral aneurysms originate at the site of medial defects? Microscopic examinations of experimental aneurysms at the fenestration of the anterior cerebral artery in rats. Surg. Neurol. 1998, 50, 141–146. [Google Scholar] [CrossRef]
  59. Guo, D.; Wang, Y.W.; Ma, J.; Yan, L.; Li, T.F.; Han, X.W.; Shui, S.F. Study on the role of Cathepsin B and JNK signaling pathway in the development of cerebral aneurysm. Asian Pac. J. Trop. Med. 2016, 9, 499–502. [Google Scholar] [CrossRef] [Green Version]
  60. Hazama, F.; Kataoka, H.; Yamada, E.; Kayembe, K.; Hashimoto, N.; Kojima, M.; Kim, C. Early changes of experimentally induced cerebral aneurysms in rats. Light-microscopic study. Am. J. Pathol. 1986, 124, 399–404. [Google Scholar]
  61. Ishibashi, R.; Aoki, T.; Nishimura, M.; Hashimoto, N.; Miyamoto, S. Contribution of mast cells to cerebral aneurysm formation. Curr. Neurovasc. Res. 2010, 7, 113–124. [Google Scholar] [CrossRef] [PubMed]
  62. Jamous, M.A.; Nagahiro, S.; Kitazato, K.T.; Satoh, K.; Satomi, J. Vascular corrosion casts mirroring early morphological changes that lead to the formation of saccular cerebral aneurysm: An experimental study in rats. J. Neurosurg. 2005, 102, 532–535. [Google Scholar] [CrossRef] [PubMed]
  63. Jamous, M.A.; Nagahiro, S.; Kitazato, K.T.; Satomi, J.; Satoh, K. Role of estrogen deficiency in the formation and progression of cerebral aneurysms. Part I: Experimental study of the effect of oophorectomy in rats. J. Neurosurg. 2005, 103, 1046–1051. [Google Scholar] [CrossRef]
  64. Jamous, M.A.; Nagahiro, S.; Kitazato, K.T.; Tamura, T.; Kuwayama, K.; Satoh, K. Role of estrogen deficiency in the formation and progression of cerebral aneurysms. Part II: Experimental study of the effects of hormone replacement therapy in rats. J. Neurosurg. 2005, 103, 1052–1057. [Google Scholar] [CrossRef]
  65. Jamous, M.A.; Nagahiro, S.; Kitazato, K.T.; Tamura, T.; Aziz, H.A.; Shono, M.; Satoh, K. Endothelial injury and inflammatory response induced by hemodynamic changes preceding intracranial aneurysm formation: Experimental study in rats. J. Neurosurg. 2007, 107, 405–411. [Google Scholar] [CrossRef]
  66. Kang, Y.; Hashimoto, N.; Kikuchi, H.; Yamazoe, N.; Hazama, F. Effects of blood coagulation factor XIII on the development of experimental cerebral aneurysms in rats. J. Neurosurg. 1990, 73, 242–247. [Google Scholar] [CrossRef]
  67. Kim, C.; Kikuchi, H.; Hashimoto, N.; Kojima, M.; Kang, Y.; Hazama, F. Involvement of internal elastic lamina in development of induced cerebral aneurysms in rats. Stroke 1988, 19, 507–511. [Google Scholar] [CrossRef] [Green Version]
  68. Kim, C.; Cervos-Navarro, J.; Kikuchi, H.; Hashimoto, N.; Hazama, F. Degenerative changes in the internal elastic lamina relating to the development of saccular cerebral aneurysms in rats. Acta Neurochir. (Wien) 1993, 121, 76–81. [Google Scholar] [CrossRef]
  69. Kimura, N.; Shimizu, H.; Eldawoody, H.; Nakayama, T.; Saito, A.; Tominaga, T.; Takahashi, A. Effect of olmesartan and pravastatin on experimental cerebral aneurysms in rats. Brain Res. 2010, 1322, 144–152. [Google Scholar] [CrossRef]
  70. Kojima, M.; Handa, H.; Hashimoto, N.; Kim, C.; Hazama, F. Early changes of experimentally induced cerebral aneurysms in rats: Scanning electron microscopic study. Stroke 1986, 17, 835–841. [Google Scholar] [CrossRef] [Green Version]
  71. Kondo, S.; Hashimoto, N.; Kikuchi, H.; Hazama, F.; Nagata, I.; Kataoka, H. Cerebral aneurysms arising at nonbranching sites. An experimental Study. Stroke 1997, 28, 398–403. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  72. Kondo, S.; Hashimoto, N.; Kikuchi, H.; Hazama, F.; Nagata, I.; Kataoka, H. Apoptosis of medial smooth muscle cells in the development of saccular cerebral aneurysms in rats. Stroke 1998, 29, 181–188. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  73. Korai, M.; Kitazato, K.T.; Tada, Y.; Miyamoto, T.; Shimada, K.; Matsushita, N.; Kanematsu, Y.; Satomi, J.; Hashimoto, T.; Nagahiro, S. Hyperhomocysteinemia induced by excessive methionine intake promotes rupture of cerebral aneurysms in ovariectomized rats. J. Neuroinflamm. 2016, 13, 165. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  74. Li, S.; Tian, Y.; Huang, X.; Zhang, Y.; Wang, D.; Wei, H.; Dong, J.; Jiang, R.; Zhang, J. Intravenous transfusion of endothelial colony-forming cells attenuates vascular degeneration after cerebral aneurysm induction. Brain Res. 2014, 1593, 65–75. [Google Scholar] [CrossRef] [PubMed]
  75. Li, S.; Wang, D.; Tian, Y.; Wei, H.; Zhou, Z.; Liu, L.; Wang, D.; Dong, J.F.; Jiang, R.; Zhang, J. Aspirin inhibits degenerative changes of aneurysmal wall in a rat model. Neurochem. Res. 2015, 40, 1537–1545. [Google Scholar] [CrossRef]
  76. Maekawa, H.; Tada, Y.; Yagi, K.; Miyamoto, T.; Kitazato, K.T.; Korai, M.; Satomi, J.; Hashimoto, T.; Nagahiro, S. Bazedoxifene, a selective estrogen receptor modulator, reduces cerebral aneurysm rupture in Ovariectomized rats. J. Neuroinflamm. 2017, 14, 197. [Google Scholar] [CrossRef]
  77. Miyamoto, T.; Kung, D.K.; Kitazato, K.T.; Yagi, K.; Shimada, K.; Tada, Y.; Korai, M.; Kurashiki, Y.; Kinouchi, T.; Kanematsu, Y.; et al. Site-specific elevation of interleukin-1beta and matrix metalloproteinase-9 in the Willis circle by hemodynamic changes is associated with rupture in a novel rat cerebral aneurysm model. J. Cereb. Blood Flow Metab. 2017, 37, 2795–2805. [Google Scholar] [CrossRef] [Green Version]
  78. Nagata, I.; Handa, H.; Hashimoto, N. Experimentally induced cerebral aneurysms in rats: Part IV—Cerebral angiography. Surg. Neurol. 1979, 12, 419–424. [Google Scholar]
  79. Nagata, I.; Handa, H.; Hashimoto, N.; Hazama, F. Experimentally induced cerebral aneurysms in rats: Part VI. Hypertension. Surg. Neurol. 1980, 14, 477–479. [Google Scholar]
  80. Nagata, I.; Handa, H.; Hasimoto, N.; Hazama, F. Experimentally induced cerebral aneurysms in rats: VII. Scanning electron microscope study. Surg. Neurol. 1981, 16, 291–296. [Google Scholar] [CrossRef]
  81. Nakatani, H.; Hashimoto, N.; Kikuchi, H.; Yamaguchi, S.; Niimi, H. In vivo flow visualization of induced saccular cerebral aneurysms in rats. Acta Neurochir. (Wien) 1993, 122, 244–249. [Google Scholar] [CrossRef] [PubMed]
  82. Sadamasa, N.; Nozaki, K.; Takagi, Y.; Moriwaki, T.; Kawanabe, Y.; Ishikawa, M.; Hashimoto, N. Cerebral aneurysm progression suppressed by blockage of endothelin B receptor. J. Neurosurg. 2007, 106, 330–336. [Google Scholar] [CrossRef] [PubMed]
  83. Sadamasa, N.; Nozaki, K.; Kita-Matsuo, H.; Saito, S.; Moriwaki, T.; Aoki, T.; Kawarazaki, S.; Kataoka, H.; Takagi, Y.; Ishikawa, M.; et al. Gene expression during the development of experimentally induced cerebral aneurysms. J. Vasc. Res. 2008, 45, 343–349. [Google Scholar] [CrossRef] [PubMed]
  84. Tada, Y.; Yagi, K.; Kitazato, K.T.; Tamura, T.; Kinouchi, T.; Shimada, K.; Matsushita, N.; Nakajima, N.; Satomi, J.; Kageji, T.; et al. Reduction of endothelial tight junction proteins is related to cerebral aneurysm formation in rats. J. Hypertens. 2010, 28, 1883–1891. [Google Scholar] [CrossRef]
  85. Tada, Y.; Kitazato, K.T.; Yagi, K.; Shimada, K.; Matsushita, N.; Kinouchi, T.; Kanematsu, Y.; Satomi, J.; Kageji, T.; Nagahiro, S. Statins promote the growth of experimentally induced cerebral aneurysms in estrogen-deficient rats. Stroke 2011, 42, 2286–2293. [Google Scholar] [CrossRef]
  86. Tamura, T.; Jamous, M.A.; Kitazato, K.T.; Yagi, K.; Tada, Y.; Uno, M.; Nagahiro, S. Endothelial damage due to impaired nitric oxide bioavailability triggers cerebral aneurysm formation in female rats. J. Hypertens. 2009, 27, 1284–1292. [Google Scholar] [CrossRef]
  87. Yagi, K.; Tada, Y.; Kitazato, K.T.; Tamura, T.; Satomi, J.; Nagahiro, S. Ibudilast inhibits cerebral aneurysms by down-regulating inflammation-related molecules in the vascular wall of rats. Neurosurgery 2010, 66, 551–559. [Google Scholar] [CrossRef]
  88. Yamazoe, N.; Hashimoto, N.; Kikuchi, H.; Hazama, F. Elastic skeleton of intracranial cerebral aneurysms in rats. Stroke 1990, 21, 1722–1726. [Google Scholar] [CrossRef] [Green Version]
  89. Yokoi, T.; Isono, T.; Saitoh, M.; Yoshimura, Y.; Nozaki, K. Suppression of cerebral aneurysm formation in rats by a tumor necrosis factor-alpha inhibitor. J. Neurosurg. 2014, 120, 1193–1200. [Google Scholar] [CrossRef] [Green Version]
  90. Wu, C.; Liu, Y.; He, M.; Zhu, L.; You, C. Single operation with simplified incisions to build an experimental cerebral aneurysm model by induced hemodynamic stress and estrogen deficiency in rats. Turk. Neurosurg. 2016, 26, 62–68. [Google Scholar] [CrossRef] [Green Version]
  91. Zhou, D.; Bao, Y.D.; Du, Z.W.; Takeda, F.; Kanno, T. Experimental cerebral aneurysms in rats. Experimental method and effect of estradiol. Chin. Med. J. (Engl.) 1985, 98, 421–426. [Google Scholar] [PubMed]
  92. Sadamasa, N.; Nozaki, K.; Hashimoto, N. Disruption of gene for inducible nitric oxide synthase reduces progression of cerebral aneurysms. Stroke 2003, 34, 2980–2984. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  93. Zhao, J.; Lin, X.; He, C.; Yang, G.Y.; Ling, F. Study of cerebral aneurysms in a modified rat model: From real-time imaging to histological analysis. J. Clin. Neurosci. 2015, 22, 373–377. [Google Scholar] [CrossRef] [PubMed]
  94. Chalouhi, N.; Starke, R.M.; Correa, T.; Jabbour, P.M.; Zanaty, M.; Brown, R.D., Jr.; Torner, J.C.; Hasan, D.M. Differential sex response to aspirin in decreasing aneurysm rupture in humans and mice. Hypertension 2016, 68, 411–417. [Google Scholar] [CrossRef]
  95. Chu, Y.; Wilson, K.; Gu, H.; Wegman-Points, L.; Dooley, S.A.; Pierce, G.L.; Cheng, G.; Pena Silva, R.A.; Heistad, D.D.; Hasan, D. Myeloperoxidase is increased in human cerebral aneurysms and increases formation and rupture of cerebral aneurysms in mice. Stroke 2015, 46, 1651–1656. [Google Scholar] [CrossRef] [Green Version]
  96. Hasan, D.M.; Starke, R.M.; Gu, H.; Wilson, K.; Chu, Y.; Chalouhi, N.; Heistad, D.D.; Faraci, F.M.; Sigmund, C.D. Smooth muscle peroxisome proliferator-activated receptor gamma plays a critical role in formation and rupture of cerebral aneurysms in mice in vivo. Hypertension 2015, 66, 211–220. [Google Scholar] [CrossRef] [Green Version]
  97. Kanematsu, Y.; Kanematsu, M.; Kurihara, C.; Tada, Y.; Tsou, T.L.; van Rooijen, N.; Lawton, M.T.; Young, W.L.; Liang, E.I.; Nuki, Y.; et al. Critical roles of macrophages in the formation of intracranial aneurysm. Stroke 2011, 42, 173–178. [Google Scholar] [CrossRef] [Green Version]
  98. Kuwabara, A.; Liu, J.; Kamio, Y.; Liu, A.; Lawton, M.T.; Lee, J.W.; Hashimoto, T. Protective effect of mesenchymal stem cells against the development of intracranial aneurysm rupture in mice. Neurosurgery 2017, 81, 1021–1028. [Google Scholar] [CrossRef]
  99. Labeyrie, P.E.; Goulay, R.; Martinez de Lizarrondo, S.; Hebert, M.; Gauberti, M.; Maubert, E.; Delaunay, B.; Gory, B.; Signorelli, F.; Turjman, F.; et al. Vascular tissue-type plasminogen activator promotes intracranial aneurysm formation. Stroke 2017, 48, 2574–2582. [Google Scholar] [CrossRef]
  100. Lee, J.A.; Marshman, L.A.; Moran, C.S.; Kuma, L.; Guazzo, E.P.; Anderson, D.S.; Golledge, J. A small animal model for early cerebral aneurysm pathology. J. Clin. Neurosci. 2016, 34, 259–263. [Google Scholar] [CrossRef]
  101. Liu, J.; Kuwabara, A.; Kamio, Y.; Hu, S.; Park, J.; Hashimoto, T.; Lee, J.W. Human mesenchymal stem cell-derived microvesicles prevent the rupture of intracranial aneurysm in part by suppression of mast cell activation via a pge2-dependent mechanism. Stem Cells 2016, 34, 2943–2955. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  102. Liu, M.; Zhao, J.; Zhou, Q.; Peng, Y.; Zhou, Y.; Jiang, Y. Primary cilia deficiency induces intracranial aneurysm. Shock 2018, 49, 604–611. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  103. Makino, H.; Tada, Y.; Wada, K.; Liang, E.I.; Chang, M.; Mobashery, S.; Kanematsu, Y.; Kurihara, C.; Palova, E.; Kanematsu, M.; et al. Pharmacological stabilization of intracranial aneurysms in mice: A feasibility study. Stroke 2012, 43, 2450–2456. [Google Scholar] [CrossRef] [Green Version]
  104. Makino, H.; Hokamura, K.; Natsume, T.; Kimura, T.; Kamio, Y.; Magata, Y.; Namba, H.; Katoh, T.; Sato, S.; Hashimoto, T.; et al. Successful serial imaging of the mouse cerebral arteries using conventional 3-T magnetic resonance imaging. J. Cereb. Blood Flow Metab. 2015, 35, 1523–1527. [Google Scholar] [CrossRef] [Green Version]
  105. Nuki, Y.; Tsou, T.L.; Kurihara, C.; Kanematsu, M.; Kanematsu, Y.; Hashimoto, T. Elastase-induced intracranial aneurysms in hypertensive mice. Hypertension 2009, 54, 1337–1344. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  106. Pena Silva, R.A.; Kung, D.K.; Mitchell, I.J.; Alenina, N.; Bader, M.; Santos, R.A.; Faraci, F.M.; Heistad, D.D.; Hasan, D.M. Angiotensin 1–7 reduces mortality and rupture of intracranial aneurysms in mice. Hypertension 2014, 64, 362–368. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  107. Pena-Silva, R.A.; Chalouhi, N.; Wegman-Points, L.; Ali, M.; Mitchell, I.; Pierce, G.L.; Chu, Y.; Ballas, Z.K.; Heistad, D.; Hasan, D. Novel role for endogenous hepatocyte growth factor in the pathogenesis of intracranial aneurysms. Hypertension 2015, 65, 587–593. [Google Scholar] [CrossRef] [Green Version]
  108. Shimada, K.; Furukawa, H.; Wada, K.; Korai, M.; Wei, Y.; Tada, Y.; Kuwabara, A.; Shikata, F.; Kitazato, K.T.; Nagahiro, S.; et al. Protective role of peroxisome proliferator-activated receptor-gamma in the development of intracranial aneurysm rupture. Stroke 2015, 46, 1664–1672. [Google Scholar] [CrossRef] [Green Version]
  109. Shimada, K.; Furukawa, H.; Wada, K.; Wei, Y.; Tada, Y.; Kuwabara, A.; Shikata, F.; Kanematsu, Y.; Lawton, M.T.; Kitazato, K.T.; et al. Angiotensin-(1-7) protects against the development of aneurysmal subarachnoid hemorrhage in mice. J. Cereb. Blood Flow Metab. 2015, 35, 1163–1168. [Google Scholar] [CrossRef]
  110. Tada, Y.; Makino, H.; Furukawa, H.; Shimada, K.; Wada, K.; Liang, E.I.; Murakami, S.; Kudo, M.; Kung, D.K.; Hasan, D.M.; et al. Roles of estrogen in the formation of intracranial aneurysms in ovariectomized female mice. Neurosurgery 2014, 75, 690–695. [Google Scholar] [CrossRef] [Green Version]
  111. Tada, Y.; Wada, K.; Shimada, K.; Makino, H.; Liang, E.I.; Murakami, S.; Kudo, M.; Kitazato, K.T.; Nagahiro, S.; Hashimoto, T. Roles of hypertension in the rupture of intracranial aneurysms. Stroke 2014, 45, 579–586. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  112. Tada, Y.; Wada, K.; Shimada, K.; Makino, H.; Liang, E.I.; Murakami, S.; Kudo, M.; Shikata, F.; Pena Silva, R.A.; Kitazato, K.T.; et al. Estrogen protects against intracranial aneurysm rupture in ovariectomized mice. Hypertension 2014, 63, 1339–1344. [Google Scholar] [CrossRef] [Green Version]
  113. Wada, K.; Makino, H.; Shimada, K.; Shikata, F.; Kuwabara, A.; Hashimoto, T. Translational research using a mouse model of intracranial aneurysm. Transl. Stroke Res. 2014, 5, 248–251. [Google Scholar] [CrossRef] [Green Version]
  114. Zhang, M.; Ren, Y.; Wang, Y.; Wang, R.; Zhou, Q.; Peng, Y.; Li, Q.; Yu, M.; Jiang, Y. Regulation of smooth muscle contractility by competing endogenous mRNAs in intracranial aneurysms. J. Neuropathol. Exp. Neurol. 2015, 74, 411–424. [Google Scholar] [CrossRef] [Green Version]
  115. Dai, D.; Ding, Y.H.; Kadirvel, R.; Lewis, D.A.; Kallmes, D.F. Experience with microaneurysm formation at the basilar terminus in the rabbit elastase aneurysm model. AJNR Am. J. Neuroradiol. 2010, 31, 300–303. [Google Scholar] [CrossRef]
  116. Yasuda, H.; Kuroda, S.; Nanba, R.; Ishikawa, T.; Shinya, N.; Terasaka, S.; Iwasaki, Y.; Nagashima, K. A novel coating biomaterial for intracranial aneurysms: Effects and safety in extra- and intracranial carotid artery. Neuropathology 2005, 25, 66–76. [Google Scholar] [CrossRef]
  117. Hoh, B.L.; Hosaka, K.; Downes, D.P.; Nowicki, K.W.; Wilmer, E.N.; Velat, G.J.; Scott, E.W. Stromal cell-derived factor-1 promoted angiogenesis and inflammatory cell infiltration in aneurysm walls. J. Neurosurg. 2014, 120, 73–86. [Google Scholar] [CrossRef] [Green Version]
  118. Hosaka, K.; Downes, D.P.; Nowicki, K.W.; Hoh, B.L. Modified murine intracranial aneurysm model: Aneurysm formation and rupture by elastase and hypertension. J. Neurointerv. Surg. 2014, 6, 474–479. [Google Scholar] [CrossRef] [Green Version]
  119. Hosaka, K.; Rojas, K.; Fazal, H.Z.; Schneider, M.B.; Shores, J.; Federico, V.; McCord, M.; Lin, L.; Hoh, B. Monocyte chemotactic protein-1-interleukin-6-osteopontin pathway of intra-aneurysmal tissue healing. Stroke 2017, 48, 1052–1060. [Google Scholar] [CrossRef] [Green Version]
  120. Nowicki, K.W.; Hosaka, K.; Walch, F.J.; Scott, E.W.; Hoh, B.L. M1 macrophages are required for murine cerebral aneurysm formation. J. Neurointerv. Surg. 2018, 10, 93–97. [Google Scholar] [CrossRef]
  121. Lee, J.; Berry, C.L. Cerebral micro-aneurysm formation in the hypertensive rat. J. Pathol. 1978, 124, 7–11. [Google Scholar] [CrossRef] [PubMed]
  122. Tada, Y.; Kitazato, K.T.; Tamura, T.; Yagi, K.; Shimada, K.; Kinouchi, T.; Satomi, J.; Nagahiro, S. Role of mineralocorticoid receptor on experimental cerebral aneurysms in rats. Hypertension 2009, 54, 552–557. [Google Scholar] [CrossRef] [PubMed]
  123. Jung, K.H.; Chu, K.; Lee, S.T.; Shin, Y.W.; Lee, K.J.; Park, D.K.; Yoo, J.S.; Kim, S.; Kim, M.; Lee, S.K.; et al. Experimental induction of cerebral aneurysms by developmental low copper diet. J. Neuropathol. Exp. Neurol. 2016, 75, 455–463. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  124. Bo, L.J.; Miao, Z.; Wang, Z.F.; Zhang, K.Z.; Gao, Z. A study on effect of curcumin on anticerebral aneurysm in the male albino rats. Brain Behav. 2017, 7, e00729. [Google Scholar] [CrossRef] [Green Version]
  125. Ebina, K.; Iwabuchi, T.; Suzuki, S. A clinico-experimental study on various wrapping materials of cerebral aneurysms. Acta Neurochir. (Wien) 1984, 72, 61–71. [Google Scholar] [CrossRef]
  126. Nishikawa, M.; Smith, R.D.; Yonekawa, Y. Experimental intracranial aneurysms. Surg. Neurol. 1977, 7, 241–244. [Google Scholar]
  127. Gopal, K.; Nagarajan, P.; Raj, T.A.; Jahan, P.; Ganapathy, H.S.; Mahesh Kumar, M.J. Effect of dietary beta carotene on cerebral aneurysm and subarachnoid haemorrhage in the brain apo E−/− mice. J. Thromb. Thrombolysis 2011, 32, 343–355. [Google Scholar] [CrossRef]
  128. CAMARADES. Collaborative Approach to Meta-Analysis and Review of Animal Data from Experimental Studies. Available online: http://www.dcn.ed.ac.uk/camarades/ (accessed on 1 August 2019).
Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow chart for study selection.
Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow chart for study selection.
Brainsci 10 00134 g001
Figure 2. Meta-analysis of all intracranial aneurysm models to determine the shortest required study period for intracranial aneurysm (IA) generation. Common carotid artery (CA) ligation alone or in combination with renal artery (RA) ligation typically involved a period of several months, while intracranial aneurysms could be created by elastase injection with or without common carotid artery ligation in one month or less. Bars indicate mean + SD.
Figure 2. Meta-analysis of all intracranial aneurysm models to determine the shortest required study period for intracranial aneurysm (IA) generation. Common carotid artery (CA) ligation alone or in combination with renal artery (RA) ligation typically involved a period of several months, while intracranial aneurysms could be created by elastase injection with or without common carotid artery ligation in one month or less. Bars indicate mean + SD.
Brainsci 10 00134 g002
Table 1. Overview of included studies. The most commonly used model in rats was common carotid artery (CCA) ligation and renal artery (RA) ligation, in mice elastase injection, and in rabbits CCA ligation.
Table 1. Overview of included studies. The most commonly used model in rats was common carotid artery (CCA) ligation and renal artery (RA) ligation, in mice elastase injection, and in rabbits CCA ligation.
CategorySubcategoryReferences
CCA ligation Unilateral CCA ligationRat: Alvarez et al. 1986 [8], Cai et al. 2012 [9], Coutard et al. 2000 [10], Hahimoto et al. 1978 [11], 1979a [12], 1979b [13], 1980 [14], Ishibashi et al. 2012 [15], Kaufmann et al. 2006 [16], Matsushita et al. 2012 [17], Suzuki et al. 1980 [18], Roda et al. 1988 [19], Xu et al. 2011a [20], 2011b [21]
Mouse: Abruzzo et al. 2007 [22]
Rabbit: Dai et al. 2013 [23], Gao et al. 2008 [24]
Bilateral CCA ligationRat: Tutino et al. 2016 [25]
Rabbit: Dolan et al. 2013 [26], Kolega et al. 2011 [27], Li et al. 2014 [28], Liaw et al. 2014 [29], Mandelbaum et al. 2013 [30], Metaxa et al. 2010 [31], Tutino et al. 2014 [32], 2015 [33]
CCA ligation and RA ligationUnilateral CCA ligationUnilateral RA ligationRat: Aoki 2007 [34], 2014 [35], Coutard et al. 1997 [36], Fukuda et al. 2014 [37], Ikedo et al. 2017 [38], Miyata et al. 2017 [39], Yamamoto et al. 2017 [40]
Mouse: Aoki et al. 2007 [34], 2017, Moriwaki et al. 2006 [41]
Rabbit: Gao et al. 2008 [24]
Bilateral RA ligationRat: Alvarez and Roda 1986 [8], Aoki et al. 2007a [42], 2007b [43], 2008a [44], 2008b [45], 2008c [46], 2008d [47], 2009 [48], 2010a [49], 2010b [50], 2011 [51], 2012 [52], 2017a [53], 2017b [54], Eldawoody et al. 2009 [55], Futami et al. 1995a [56], 1995b [57], 1998 [58], Guo et al. 2016 [59], Hazama et al. 1986 [60], Ishibashi et al. 2010 [61], Jamous et al. 2005a [62], 2005b [63], 2005c [64], 2007 [65], Kang et al. 1990 [66], Kim et al. 1988 [67], Kim et al. 1993 [68], Kimura et al. 2010 [69], Kojima et al. 1986 [70], Kondo et al. 1997 [71], 1998 [72], Korai et al. 2016 [73], Li et al. 2014 [74], 2015 [75], Maekawa et al. 2017 [76], Miyamoto et al. 2017 [77], Nagata et al. 1979 [78], 1980 [79], 1981 [80], Nakatani et al. 1993 [81], Sadamasa et al. 2007 [82], 2008 [83], Tada et al. 2010 [84], 2011 [85], Tamura et al. 2009 [86], Yagi et al. 2010 [87], Yamazoe et al. 1990 [88], Yokoi et al. 2014 [89], Wu et al. 2016 [90], Zhou et al. 1985 [91]
Mouse: Sadamasa et al. 2003 [92]
Elastase injectionRat: Zhao et al. 2015 [93]
Mouse: Chalouhi et al. 2016 [94], Chu et al. 2015 [95], Hasan et al. 2015 [96], Kanematsu et al. 2011 [97], Kuwabara et al. 2017 [98], Labeyrie et al. 2017 [99], Lee et al. 2016 [100], Liu et al. 2016 [101], 2017 [102], Makino et al. 2012 [103], 2015 [104], Nuki et al. 2009 [105], Pena Silva et al. 2014 [106], 2015 [107], Shimada et al. 2015a [108], 2015b [109], Tada et al. 2014a [110], 2014b [111], 2014c [112], Wada et al. 2014 [113], Zhang et al. 2015 [114]
Rabbit: Dai et al. 2010 [115], Yasuda et al. 2005 [116]
Elastase injection and CCA ligationMouse: Hoh et al. 2014 [117], Hosaka et al. 2014 [118], 2017 [119], Nowicki et al. 2017 [120]
OtherDeoxycorticosterone/hypertensionLee et al. 1978 [121] (rat)
EplerenoneTada et al. 2009 [122] (rat)
Copper deficiencyJung et al. 2016 [123] (rat)
CaCl2Bo et al. 2017 [124] (rat)
Coating of internal carotid arteryEbina et al. 1984 [125] (dog)
Venous pouch or venous patchNishikawa et al. 1977 [126] (dog)
Table 2. Number of aneurysm type per species in the included studies. The vast majority (76%) of studies in rats used a combined CCA ligation and RA ligation model, whereas most mouse studies (68%) used an Elastase only model. CCA = common carotid artery; RA = renal artery.
Table 2. Number of aneurysm type per species in the included studies. The vast majority (76%) of studies in rats used a combined CCA ligation and RA ligation model, whereas most mouse studies (68%) used an Elastase only model. CCA = common carotid artery; RA = renal artery.
SpeciesTotal No. of Studies AnalyzedCCA Ligation and RA LigationCCA Ligation OnlyElastase OnlyElastase and CCA LigationOther
Mice 3141214-
Rats 7960131-5
Rabbits 21-1011-
Dogs 2----2
Overall13364242256
Table 3. Mean time of aneurysm formation in months (range).
Table 3. Mean time of aneurysm formation in months (range).
SpeciesCCA Ligation and RA LigationCCA Ligation OnlyElastase OnlyElastase and CCA LigationOther
Mice (31)3,4 (0,5–5)13 (0)0,53 (0,17–1)0,43 (0,1–0,75)-
Rats (79)2,28 (0,17–12)2,49 (0,25–12)1,25 (0)-1,83 (1–2,5)
Rabbits (12)3,02,59 (0,17–6)1,5 (1–2)-
Dogs (2)----0,68 (0,35–1)
Overall2,38 (0,17–12)2,53 (0,17–13)0,65 (0,17–2)0,43 (0,1–0,75)1,37 (0,35–2,5)
Table 4. Variations to established IA models pertaining to the technique to induce hypertension and weaken vessel walls.
Table 4. Variations to established IA models pertaining to the technique to induce hypertension and weaken vessel walls.
TechniquePurposeNumber of StudiesNumber of Species
RA ligation, unilateralHypertension123
RA ligation, bilateralHypertension522
High NaCl diet (1% or 8%)Hypertension683
Deoxycorticosterone administrationHypertension153
Angiotensin IIHypertension131
β-aminopropionitrile administration (0.12%) Weakening of vessel walls362
Estrogen depletion/oophorectomyWeakening of vessel walls123
Note: several methods may have been used concomitantly in the same animal or study. High NaCl diet followed by bilateral RA ligation were the most commonly used techniques. RA = renal artery; NaCl = sodium chloride.

Share and Cite

MDPI and ACS Style

Strange, F.; Grüter, B.E.; Fandino, J.; Marbacher, S. Preclinical Intracranial Aneurysm Models: A Systematic Review. Brain Sci. 2020, 10, 134. https://doi.org/10.3390/brainsci10030134

AMA Style

Strange F, Grüter BE, Fandino J, Marbacher S. Preclinical Intracranial Aneurysm Models: A Systematic Review. Brain Sciences. 2020; 10(3):134. https://doi.org/10.3390/brainsci10030134

Chicago/Turabian Style

Strange, Fabio, Basil E Grüter, Javier Fandino, and Serge Marbacher. 2020. "Preclinical Intracranial Aneurysm Models: A Systematic Review" Brain Sciences 10, no. 3: 134. https://doi.org/10.3390/brainsci10030134

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop